Osteoarthritis News and Research

Latest Osteoarthritis News and Research

Biovail's patent infringement lawsuit against Cary Pharma may affect IntelGenx revenues

IntelGenx Corp. (TSX VENTURE:IGX)(OTCBB:IGXT) ("IntelGenx") previously announced that the New Drug Application (NDA) filing for the antidepressant CPI-300, which it developed with Cary Pharmaceuticals ("Cary Pharma") had been accepted by the U.S. Food and Drug Administration (FDA) for standard review. CPI-300 is a novel, high strength of Bupropion HCl, the active ingredient in Wellbutrin XL®.

24 Aug 2009

Health Canada approves Anika Therapeutics' MONOVISC drug

Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair based on hyaluronic acid (HA) technology, today announced that it has received Health Canada approval for MONOVISC™, its single injection viscosupplement approved for the treatment of osteoarthritis of the knee. Anika expects to launch MONOVISC this month through its long-term ORTHOVISC® distribution partner in Canada, Rivex Pharma Inc., the specialty drug distribution division of Aurora, Ontario-based Helix BioPharma Corp. (TSX: HBP). MONOVISC has been broadly available in the European Union since the second quarter of 2008.

21 Aug 2009

Brooks Rehabilitation's new specialty clinic to provide advanced treatments for back and neck

Brooks Rehabilitation's newest specialty clinic, the Brooks Center for Back & Neck Health, offers patients advanced treatments for both acute and chronic conditions of the spine, including whiplash, lumbar stenosis, cervical or lumbar radiculopathy, cervical or lumbar instability, sciatica, TMJ, osteoarthritis, degenerative disc disease, and more. According to the National Institutes of Health, back pain is the second most common reason Americans go to the doctor (headaches are the first), and among the most common reasons for surgery. Research has demonstrated the effectiveness of physical therapy for affecting outcomes in patients with spinal conditions.

19 Aug 2009

Cognitive behavioral therapy improves sleep and pain in osteoarthritis

A study in the Aug. 15 issue of the Journal of Clinical Sleep Medicine shows that the use of cognitive behavioral therapy for insomnia (CBT-I) is an effective treatment for older patients with osteoarthritis and comorbid insomnia.

16 Aug 2009

How to stop osteoarthritis pain

When arthritis affects the hands, a range of treatments may reduce pain and preserve joint mobility. The August issue of Mayo Clinic Health Letter provides an overview.

13 Aug 2009

Biochemics and Pacific Pharmaceutical to collaborate on skin products

BioChemics, Inc. (BCI) has announced the signing of a research collaboration agreement with Pacific Pharmaceutical Co., Ltd, a publicly held Company in South Korea to evaluate the use of BCI's VALE® based compositions in cosmetic applications.

6 Aug 2009

Protein level may predict severe osteoarthritis

Osteoarthritis (OA), the most common joint disorder throughout the world and a leading cause of disability, is characterized by pain, impaired joint mobility, reduction of muscular strength and loss of joint function. Unlike most other common diseases, little is known about its origins, and factors predicting a severe disease course have not been identified.

30 Jul 2009

Identification of progressors in osteoarthritis by combining biochemical and MRI-based markers

A combination of biochemical and MRI markers will allow improved measurement of osteoarthritis (OA) progression. The biomarkers, described in BioMed Central's open access journal Arthritis Research and Therapy, will be useful for the design and interpretation of trials of new disease modifying drugs.

23 Jul 2009

Early inflammatory signs of osteoarthritis

Researchers at The University of Nottingham are hoping to find out if inflammation of the knee could be an early sign of osteoarthritis - a condition which leads to pain, stiffness, swelling and disability.

23 Jul 2009

Obesity associated with increased risk of rapid cartilage loss

Obesity, among other factors, is strongly associated with an increased risk of rapid cartilage loss, according to a study published in the August issue of Radiology.

14 Jul 2009

Muscle rubs for pain in adults – no evidence they work

There is not enough evidence to support using gels and creams containing rubefacients for chronic and acute pain, according to a systematic review by Cochrane Researchers. Rubefacients cause irritation and reddening of the skin, due to increased blood flow. The review focused on formulations containing salicylates, which are widely prescribed or sold over the counter as topical treatments for sports injuries and muscle pain.

7 Jul 2009

Lilly resubmits Cymbalta supplemental NDA for chronic pain to FDA

Eli Lilly and Company has resubmitted its supplemental New Drug Application (sNDA) for Cymbalta (duloxetine HCl) for the management of chronic pain to the U.S. Food and Drug Administration (FDA).

3 Jun 2009

Australian food industry told to 'shape up' over fat, sugar and salt

The food industry in Australia has been told in no uncertain terms to shape up when it comes to the fat, sugar and salt content in food products.

3 Jun 2009

New U.S. patent issued for Limbrel in osteoarthritis

Primus Pharmaceuticals, Inc. has announced the issuance of a new composition of matter patent for Limbrel, the first prescription medical food product to safely meet the distinctive nutritional requirements of patients with osteoarthritis (OA). U.S. Patent #7,514,469 was recently issued by the U.S. Patent and Trademark Office.

27 May 2009

Discovery of faulty genes could reveal risk of Paget's disease

The discovery of faulty genes by Edinburgh researchers could help people with Paget's disease, a painful bone condition. Dr Omar Albagha has found three genes associated with the disease which, if detected early enough in people, could hasten diagnosis and treatment.

26 May 2009

Discovery of genetic factors that influence the age at which natural menopause occurs in women

For the first time, scientists have been able to identify genetic factors that influence the age at which natural menopause occurs in women. Ms Lisette Stolk, a researcher from Erasmus MC, Rotterdam, The Netherlands, told the annual conference of the European Society of Human Genetics today ( Monday 25 May) that a greater understanding of the factors influencing age at menopause might eventually help to improve the clinical treatment of infertile women.

25 May 2009

Arthritis may be exacerbated by computer use

According to researchers in the United States using a computer can have an impact on those suffering from arthritis.

3 May 2009

First human study of pioneering 'cell bandage' technology

A company co-founded by Professor Anthony Hollander has raised over £1.6 million to fund trials, including the first human study, of its pioneering 'cell bandage' technology, which aims to save thousands of patients from the type of knee surgery that currently leads to premature osteoarthritis.

22 Apr 2009

Menstrual cycle affects knee joints

New research from the Faculty of Kinesiology at the University of Calgary has found a connection between the laxity of a woman's knee joint and her monthly hormone cycle.

20 Apr 2009

New easy to understand guide on treatments for osteoarthritis of the knee

A new pair of plain-language guides from the Agency for Healthcare Research and Quality (AHRQ) examines the effectiveness, safety, and adverse effects of various treatments for osteoarthritis of the knee, including glucosamine and chondroitin, fluid injections, arthroscopic surgery, pain medications and other approaches.

13 Apr 2009